Goldman Group is an entrepreneurial
investment group focusing on
Who We Are
Goldman Group is an entrepreneurship group that initiates and invests in innovative companies and makes strides in biotech, predictive AI, healthcare big data, and deep technologies solutions.
We go beyond traditional investment roles as founders, investors, and strategic partners, we work closely with each company’s leadership team to drive growth, expand into new markets, and increase valuation over time.
Our team has extensive experience in different zones, former high-ranking military officials and diplomats, professors with expertise across various academic disciplines, health insurance consultants and CEOs of healthcare organizations, former enterprise CEOs, and execution of deep technologies projects on high-scale.
We are passionate about innovation and empowering visionary entrepreneurs at Goldman Group by aligning our resources and expertise with the ambitions of our portfolio companies, we aim to create lasting value and generate exceptional returns.
Our Portfolio
NKL’s primary focus is on safeguarding the hardware responsible for controlling and managing data flow within computerized networks.
In today’s interconnected world, human reliance on a complex web of IT systems, data management solutions, and digital ecosystems has become essential for daily life.
ODM provides AI services and tools for Digital Health to efficiently collect, collate, analyze and interpret medical data from multiple types of data in different contexts into a single data unit, enabling to cross correlate data and provide practical products and services as well as new insights leading to ground-breaking discoveries.
MEDPNC developed a diagnostic test using a quantitative approach that maps each tumor accurately and unambiguously based on its molecular disruptions, in a way that allows adapting drug combinations to treat each individual cancer patient optimally.
MEDPNC was selected as one of the 32 “One to Watch” companies in the prestigious 2020 Spinoff Prize, organized by Nature Research and Merck.
Ticketrue is a pioneering company offering an advanced authentication technology designed to transform the haute couture and luxury fashion goods and perfume industries. Our innovative solution leverages AI models, blockchain-based cybersecurity and proprietary encryption techniques to ensure the secure and reliable transfer and purchase of authentic branded goods throughout the supply chain, up to and including the consumer.
Our Leadership
Latest News
Get in touch
INVESTORS | FOUNDERS | CORPORATIONS | STARTUPS
We are always eager to create meaningful partnerships.
Seeking promising ventures? Get in touch and let us help you navigate the world of investment opportunities
Ready to accelerate your growth? Get in touch and let's empower your startup to reach its full potential
- +972-9-7711806
- info@goldmanhirsh.com
- Herzliya, Israel
